IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3060% above fair value
$85.35+0.12 (+0.14%)
Close on Nov 13, 2026Market cap $1.09BP/E 45.6Yield –
IRadimed ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
IRadimed's ebitda for the twelve months ending Sep 30, 2026 was $30.52M, up 18.1% year over year. For fiscal 2025 it was $27.31M, up 19.9% from the year before. Over ten years it grew 8.3% a year on average. The highest annual figure on record is $27.31M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.31M | +19.9% |
| FY2024 | Dec 31, 2024 | $22.78M | +9.5% |
| FY2023 | Dec 31, 2023 | $20.80M | +27.6% |
| FY2022 | Dec 31, 2022 | $16.30M | +45.2% |
| FY2021 | Dec 31, 2021 | $11.22M | +1826.2% |
| FY2020 | Dec 31, 2020 | $582.73K | -94.1% |
| FY2019 | Dec 31, 2019 | $9.89M | +39.1% |
| FY2018 | Dec 31, 2018 | $7.11M | +174.1% |
| FY2017 | Dec 31, 2017 | $2.59M | -78.2% |
| FY2016 | Dec 31, 2016 | $11.88M | -3.6% |
| FY2015 | Dec 31, 2015 | $12.32M | +283.2% |
| FY2014 | Dec 31, 2014 | $3.21M | +9.9% |
| FY2013 | Dec 31, 2013 | $2.93M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $8.55M | +18.5% |
| Q2 FY2026 | Jun 30, 2026 | $6.80M | -2.8% |
| Q1 FY2026 | Mar 31, 2026 | $7.69M | +36.7% |
| Q4 FY2025 | Dec 31, 2025 | $7.48M | +24.7% |
| Q3 FY2025 | Sep 30, 2025 | $7.22M | +20.5% |
| Q2 FY2025 | Jun 30, 2025 | $7.00M | +20.1% |
| Q1 FY2025 | Mar 31, 2025 | $5.63M | +13.1% |
| Q4 FY2024 | Dec 31, 2024 | $6.00M | +11.8% |
| Q3 FY2024 | Sep 30, 2024 | $5.99M | -1.4% |
| Q2 FY2024 | Jun 30, 2024 | $5.83M | +13.7% |
| Q1 FY2024 | Mar 31, 2024 | $4.97M | +18.7% |
| Q4 FY2023 | Dec 31, 2023 | $5.37M | +50.7% |
| Q3 FY2023 | Sep 30, 2023 | $6.07M | +42.0% |
| Q2 FY2023 | Jun 30, 2023 | $5.13M | +18.9% |
| Q1 FY2023 | Mar 31, 2023 | $4.19M | +19.4% |
| Q4 FY2022 | Dec 31, 2022 | $3.56M | +1.9% |
| Q3 FY2022 | Sep 30, 2022 | $4.27M | +24.7% |
| Q2 FY2022 | Jun 30, 2022 | $4.31M | +96.5% |
| Q1 FY2022 | Mar 31, 2022 | $3.51M | +66.4% |
| Q4 FY2021 | Dec 31, 2021 | $3.50M | +253.1% |
| Q3 FY2021 | Sep 30, 2021 | $3.43M | +207.2% |
| Q2 FY2021 | Jun 30, 2021 | $2.19M | – |
| Q1 FY2021 | Mar 31, 2021 | $2.11M | +94.9% |
| Q4 FY2020 | Dec 31, 2020 | $990.04K | -60.7% |
| Q3 FY2020 | Sep 30, 2020 | $1.12M | -60.3% |
| Q2 FY2020 | Jun 30, 2020 | -$2.61M | -197.9% |
| Q1 FY2020 | Mar 31, 2020 | $1.08M | -43.1% |
| Q4 FY2019 | Dec 31, 2019 | $2.52M | +22.7% |
| Q3 FY2019 | Sep 30, 2019 | $2.81M | +91.9% |
| Q2 FY2019 | Jun 30, 2019 | $2.66M | +28.1% |
| Q1 FY2019 | Mar 31, 2019 | $1.90M | +25.5% |
| Q4 FY2018 | Dec 31, 2018 | $2.05M | +53.5% |
| Q3 FY2018 | Sep 30, 2018 | $1.46M | +174.0% |
| Q2 FY2018 | Jun 30, 2018 | $2.08M | +208.6% |
| Q1 FY2018 | Mar 31, 2018 | $1.52M | +3008.8% |
| Q4 FY2017 | Dec 31, 2017 | $1.34M | -23.6% |
| Q3 FY2017 | Sep 30, 2017 | $533.95K | – |
| Q2 FY2017 | Jun 30, 2017 | $673.27K | – |
| Q1 FY2017 | Mar 31, 2017 | $48.74K | – |
| Q4 FY2016 | Dec 31, 2016 | $1.75M | – |
See a number that looks wrong?